AUTOCALLABLE MULTI DEFENDER VONTI - NOVARTIS N/ROCHE GS/ENPHASE ENERGY Share Price

Certificat

RMABSV

CH1326946170

Market Closed - Swiss Exchange 08:50:00 17/05/2024 pm IST
95 CHF +0.11% Intraday chart for AUTOCALLABLE MULTI DEFENDER VONTI - NOVARTIS N/ROCHE GS/ENPHASE ENERGY
Current month+1.06%
1 month+1.28%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/24/17 95 +0.11%
15/24/15 94.9 +0.11%
14/24/14 94.8 +0.74%

Delayed Quote Swiss Exchange

Last update May 17, 2024 at 08:50 pm IST

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMABSV
ISINCH1326946170
Date issued 23/02/2024
Maturity 23/02/2029 (1741 Days)
Parity 0.23 : 1
Emission price 100 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 97.9 CHF
Lowest since issue 92.8 CHF
Spread 10 CHF
Spread %1.04%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus
  1. Stock Market
  2. Certificates
  3. RMABSV Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW